Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles from the last 90 days matching "pulmonary-fibrosis"

NewsRSSApr 29

Test Your Knowledge About Nintedanib for the Treatment of PPF

This article is a quiz that tests what you know about nintedanib, a medication used to treat progressive pulmonary fibrosis (PPF). Progressive pulmonary fibrosis is a lung disease where lung tissue becomes scarred and stiff over time, making it harder to breathe. The quiz helps patients and caregivers learn more about how this drug works and its role in treatment.

WHY IT MATTERSUnderstanding how nintedanib works can help patients with PPF make informed decisions about their treatment options and have more meaningful conversations with their doctors about managing their condition.
ℹ Good to knowprogressive pulmonary fibrosis
NewsRSSApr 22

Test Your Knowledge About Nerandomilast for the Treatment of PPF

This article is a quiz about nerandomilast, a medicine being studied to treat progressive pulmonary fibrosis (PPF), which is a lung disease where lung tissue becomes scarred and stiff over time, making it harder to breathe. The quiz helps patients and caregivers learn more about this potential treatment option. It's a way to test your understanding of how this medicine might help people with this serious lung condition.

WHY IT MATTERSPatients with progressive pulmonary fibrosis have limited treatment options, so learning about emerging therapies like nerandomilast helps them stay informed about potential new ways to slow lung damage.
ℹ Good to knowprogressive pulmonary fibrosis
ResearchBIORXIVApr 5

Preprint: Burden of rare pathogenic variants suggests disrupted cytoskeletal organisation in the pathogenesis of pulmonary fibrosis

Researchers studied the genes of people with pulmonary fibrosis (a disease where lung tissue becomes scarred and stiff) to find rare genetic changes that might cause the disease. They found that problems in genes related to how cells maintain their structure may play an important role in developing pulmonary fibrosis. This discovery could help doctors better understand why some people develop this serious lung condition.

WHY IT MATTERSIf you or a family member has pulmonary fibrosis, this research could eventually help explain your genetic risk and lead to new treatments targeting the cellular structures that are damaged in this disease.
ℹ Good to knowIdiopathic Pulmonary FibrosisPulmonary Fibrosis

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases